Infants' Tylenol oral suspension recalled

McNeil Consumer Healthcare is voluntarily recalling seven lots of Infants' Tylenol Oral Suspension, 1oz Grape, distributed nationwide in the U.S. after consumer complaints about difficulty using the SimpleMeasure dosing system.

The affected lots are:  IL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, BJL2U00; UPC Code: 300450122308.

SimpleMeasure includes a dosing syringe, which inserts into a protective cover or "flow restrictor," at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe. If the flow restrictor is pushed into the bottle, the product should not be used.

Infants' Tylenol is an OTC product indicated as a pain reliever/fever reducer. Children's Tylenol products are intended for children two years of age and older and remain available.

More in Web Exclusives

Midlife workouts cut heart risk

Midlife workouts cut heart risk

Adults who increase their fitness level in midlife or maintain high fitness levels have lower heart failure hospitalization rates later.

HealthMap identifies online vaccine misinformation in real time

HealthMap identifies online vaccine misinformation in real time

An automated data collection system enables public health officials to categorize online vaccine information as negative or positive, and by location.

FDA approves Xofigo for advanced prostate cancer

FDA approves Xofigo for advanced prostate cancer

Xofigo has been approved three months ahead of schedule to treat men with metastatic castration-resistant prostate cancer.